BR0009289A - Uso de inibidores da vasopeptidase para tratar angina pectoris - Google Patents
Uso de inibidores da vasopeptidase para tratar angina pectorisInfo
- Publication number
- BR0009289A BR0009289A BR0009289-4A BR0009289A BR0009289A BR 0009289 A BR0009289 A BR 0009289A BR 0009289 A BR0009289 A BR 0009289A BR 0009289 A BR0009289 A BR 0009289A
- Authority
- BR
- Brazil
- Prior art keywords
- angina pectoris
- vasopeptidase inhibitors
- treat angina
- vasopeptidase
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
"USO DE INIBIDORES DA VASOPEPTIDASE PARA TRATAR ANGINA PECTORIS". Inibidores de vasopeptidase, particularmente omapatrilat, são utilizáveis no tratamento e/ou alívio dos sintomas de angina pectoris. O inibidor de vasopeptidase pode ser usado em combinação com outros agentes farmaceuticamente aceitáveis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12694299P | 1999-03-29 | 1999-03-29 | |
PCT/US2000/006091 WO2000057883A1 (en) | 1999-03-29 | 2000-03-09 | Use of vasopeptidase inhibitors to treat angina pectoris |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0009289A true BR0009289A (pt) | 2002-01-22 |
Family
ID=22427490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0009289-4A BR0009289A (pt) | 1999-03-29 | 2000-03-09 | Uso de inibidores da vasopeptidase para tratar angina pectoris |
Country Status (17)
Country | Link |
---|---|
US (1) | US6140319A (pt) |
EP (1) | EP1165088A4 (pt) |
JP (1) | JP2002540157A (pt) |
KR (1) | KR20020002487A (pt) |
CN (1) | CN1347321A (pt) |
AU (1) | AU768880B2 (pt) |
BR (1) | BR0009289A (pt) |
CA (1) | CA2368616A1 (pt) |
CZ (1) | CZ20013453A3 (pt) |
HK (1) | HK1039894A1 (pt) |
HU (1) | HUP0200662A3 (pt) |
IL (1) | IL144285A0 (pt) |
MX (1) | MXPA01009654A (pt) |
NO (1) | NO20014697L (pt) |
RU (1) | RU2245147C2 (pt) |
WO (1) | WO2000057883A1 (pt) |
ZA (1) | ZA200107962B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040198839A1 (en) * | 2000-08-23 | 2004-10-07 | Dean Herbert M. | Cardioprotective dosage units |
US20030035839A1 (en) * | 2001-05-15 | 2003-02-20 | Peirce Management, Llc | Pharmaceutical composition for both intraoral and oral administration |
EP1463510A2 (en) * | 2001-12-20 | 2004-10-06 | Bristol-Myers Squibb Company | Administration of vasopeptidase inhibitors to reduce pulse pressure |
WO2008001311A2 (en) * | 2006-06-26 | 2008-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition containing fixed dose combination of atenolol with isosorbide mononitrate |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR880007441A (ko) * | 1986-12-11 | 1988-08-27 | 알렌 제이.스피겔 | 스피로-치환된 글루타르아미드 이뇨제 |
IL98546A (en) * | 1990-06-22 | 1996-05-14 | Fisons Plc | History of Aster ECA Inhibitors Preparation and Pharmaceutical Preparations Containing Them |
GB9103454D0 (en) * | 1991-02-19 | 1991-04-03 | Pfizer Ltd | Therapeutic agents |
US5294632A (en) * | 1991-05-01 | 1994-03-15 | Ciba-Geigy Corporation | Phosphono/biaryl substituted dipetide derivatives |
US5155100A (en) * | 1991-05-01 | 1992-10-13 | Ciba-Geigy Corporation | Phosphono/biaryl substituted dipeptide derivatives |
US5250522A (en) * | 1992-10-09 | 1993-10-05 | Ciba-Geigy Corporation | Phosphono/biaryl substituted amino acid derivatives |
US5244889A (en) * | 1991-11-26 | 1993-09-14 | Ciba-Geigy Corporation | Certain macrocyclic lactam derivatives |
US5217996A (en) * | 1992-01-22 | 1993-06-08 | Ciba-Geigy Corporation | Biaryl substituted 4-amino-butyric acid amides |
US5552397A (en) * | 1992-05-18 | 1996-09-03 | E. R. Squibb & Sons, Inc. | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase |
ES2111689T3 (es) * | 1992-11-17 | 1998-03-16 | Smith & Nephew Inc | Dispositivo de bloqueo para la inmovilizacion de un hilo de sutura. |
GB9310075D0 (en) * | 1993-05-17 | 1993-06-30 | Fujisawa Pharmaceutical Co | New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
US5508272A (en) * | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
EP0706525A1 (en) * | 1993-06-30 | 1996-04-17 | Novartis AG | Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
EP0655461B1 (en) * | 1993-11-16 | 2000-06-07 | Novartis AG | Cyclic amino acid derivatives having ACE and NEP inhibiting activity |
WO1995020571A1 (en) * | 1994-01-28 | 1995-08-03 | Cal International Limited | A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor |
US5508266A (en) * | 1994-06-22 | 1996-04-16 | Ciba-Geigy Corporation | Gem-disubstituted amino acid derivatives |
FR2729668A1 (fr) * | 1995-01-23 | 1996-07-26 | Adir | Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5744781A (en) * | 1995-08-07 | 1998-04-28 | General Electric Company | Method and apparatus for laser shock peening |
WO1999065500A1 (en) * | 1998-06-17 | 1999-12-23 | Bristol-Myers Squibb Company | Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
-
2000
- 2000-03-09 JP JP2000607633A patent/JP2002540157A/ja active Pending
- 2000-03-09 BR BR0009289-4A patent/BR0009289A/pt not_active IP Right Cessation
- 2000-03-09 CZ CZ20013453A patent/CZ20013453A3/cs unknown
- 2000-03-09 CN CN00805543A patent/CN1347321A/zh active Pending
- 2000-03-09 EP EP00916174A patent/EP1165088A4/en not_active Withdrawn
- 2000-03-09 MX MXPA01009654A patent/MXPA01009654A/es unknown
- 2000-03-09 IL IL14428500A patent/IL144285A0/xx unknown
- 2000-03-09 RU RU2001124273/14A patent/RU2245147C2/ru not_active IP Right Cessation
- 2000-03-09 CA CA002368616A patent/CA2368616A1/en not_active Abandoned
- 2000-03-09 KR KR1020017012399A patent/KR20020002487A/ko not_active Application Discontinuation
- 2000-03-09 WO PCT/US2000/006091 patent/WO2000057883A1/en not_active Application Discontinuation
- 2000-03-09 HU HU0200662A patent/HUP0200662A3/hu unknown
- 2000-03-09 AU AU37321/00A patent/AU768880B2/en not_active Ceased
- 2000-03-16 US US09/527,120 patent/US6140319A/en not_active Expired - Fee Related
-
2001
- 2001-09-27 ZA ZA200107962A patent/ZA200107962B/xx unknown
- 2001-09-27 NO NO20014697A patent/NO20014697L/no not_active Application Discontinuation
-
2002
- 2002-02-18 HK HK02101174.4A patent/HK1039894A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000057883A1 (en) | 2000-10-05 |
IL144285A0 (en) | 2002-05-23 |
MXPA01009654A (es) | 2002-05-14 |
NO20014697D0 (no) | 2001-09-27 |
HK1039894A1 (zh) | 2002-05-17 |
JP2002540157A (ja) | 2002-11-26 |
NO20014697L (no) | 2001-09-27 |
ZA200107962B (en) | 2003-01-02 |
RU2245147C2 (ru) | 2005-01-27 |
KR20020002487A (ko) | 2002-01-09 |
AU768880B2 (en) | 2004-01-08 |
US6140319A (en) | 2000-10-31 |
CN1347321A (zh) | 2002-05-01 |
AU3732100A (en) | 2000-10-16 |
CA2368616A1 (en) | 2000-10-05 |
CZ20013453A3 (cs) | 2002-02-13 |
HUP0200662A3 (en) | 2004-07-28 |
EP1165088A4 (en) | 2002-09-04 |
HUP0200662A2 (hu) | 2002-07-29 |
EP1165088A1 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002302587A1 (en) | Acne treatment with lipooxigenase inhibitors | |
MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
TR199901604T2 (xx) | Tedavide yararl� kinolin ve kinazolin bile�ikleri. | |
DK0891331T3 (da) | N-(2-Oxoacetyl- eller sulfonyl)pyrrolidin/piperidin-2-carboxylsyrederivater med forbedret multi-lægemiddelresistensaktivitet | |
GB9807639D0 (en) | Anti-inflammatory agents | |
BR0014384A (pt) | Compostos para o tratamento da isquémia | |
AR033342A1 (es) | Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico | |
TR200002759T2 (tr) | Bacak uyuşması sendromunun tedavisinde kabergolin kullanımı. | |
TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
HK1024865A1 (en) | Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies | |
TR199901411T2 (xx) | Analjezik etkili yeni bile�imler. | |
ES2171356A1 (es) | Uso de combinaciones que comprenden antihistaminas no sedantes y farmacos alfa-adrenergicos para el tratamiento topico de rinitis/conjuntivitis y sintomas de catarro, tipo catarro y/o gripe. | |
HUP0100586A2 (hu) | Alsó húgyvezetéki tünetek kezelésére alkalmas gyógyászati készítmények | |
BR9810520A (pt) | Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial | |
BR0213994A (pt) | Derivados heterocìclicos de glicinamida e seus usos médicos | |
BR9807523A (pt) | Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids. | |
AU5170400A (en) | Topical application of muscarinic and opioid agents for treatment of tinnitus | |
SE9902267D0 (sv) | New compounds | |
BR0009289A (pt) | Uso de inibidores da vasopeptidase para tratar angina pectoris | |
DE60124030D1 (de) | Behandlung von Pansenacidose mit Amylasehemmern | |
UY26648A1 (es) | Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada | |
DE50113974D1 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
TR200103151T2 (tr) | Karboksipeptidaz U inhibitörü ile trombin inhibitörünü içeren farmasötik bir formülasyon. | |
BR0116554A (pt) | Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão | |
TR200002939T2 (tr) | Paroksetin maleat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
HKFN | Application deemed withdrawn (deleted) | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ,8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009. |